Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com//news-release/2024/03/05/2840286/31990/en/Agios-to-Present-at-the-Leerink-Partners-Global-Biopharma-Conference-on-March-12-2024.html
https://www.globenewswire.com//news-release/2024/02/22/2833514/31990/en/Agios-to-Present-at-the-TD-Cowen-44th-Annual-Health-Care-Conference-on-March-4-2024.html
https://www.globenewswire.com//news-release/2024/02/15/2829806/31990/en/Agios-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Recent-Business-Highlights.html
https://www.globenewswire.com//news-release/2024/02/02/2822756/31990/en/Agios-to-Webcast-Conference-Call-of-Fourth-Quarter-and-Year-End-2023-Financial-Results-on-February-15-2024.html
https://www.globenewswire.com//news-release/2024/01/08/2805239/31990/en/Agios-Announces-Key-Anticipated-2024-Milestones-Across-Rare-Disease-Portfolio.html
https://www.globenewswire.com//news-release/2024/01/03/2803114/31990/en/Agios-Announces-Phase-3-ENERGIZE-Study-of-Mitapivat-Met-Primary-Endpoint-and-Both-Key-Secondary-Endpoints-in-Adults-with-Non-Transfusion-Dependent-Alpha-or-Beta-Thalassemia.html
https://www.globenewswire.com//news-release/2024/01/02/2802565/31990/en/Agios-to-Present-at-the-42nd-Annual-J-P-Morgan-Healthcare-Conference-on-January-10-2024.html
https://www.globenewswire.com//news-release/2023/12/10/2793450/31990/en/Agios-Presents-Positive-Results-from-Phase-2-Portion-of-the-RISE-UP-Pivotal-Study-in-Sickle-Cell-Disease-at-65th-ASH-Annual-Meeting-and-Exposition.html
https://www.globenewswire.com/news-release/2023/11/20/2783104/31990/en/Agios-Announces-Clinical-Proof-of-Concept-in-Phase-2a-Trial-of-AG-946-for-the-Treatment-of-Anemia-in-Lower-Risk-Myelodysplastic-Syndromes.html
https://www.globenewswire.com//news-release/2023/11/02/2772433/31990/en/Agios-Pharmaceuticals-to-Present-Broad-Set-of-Clinical-and-Translational-Data-in-Rare-Blood-Disorders-at-65th-ASH-Annual-Meeting-and-Exposition.html